Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hajer GR et al. Atherosclerosis 2009;202:216-24

Published byἸφιγένεια Αλεξανδρίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "Hajer GR et al. Atherosclerosis 2009;202:216-24"— Presentation transcript:

1 Hajer GR et al. Atherosclerosis 2009;202:216-24

2 Baseline characteristics of study subjects
Hajer GR et al. Atherosclerosis 2009;202:216-24

3 Fasting lipid parameters at baseline and after both treatment periods
Hajer GR et al. Atherosclerosis 2009;202:216-24

4 Change of lipid levels in plasma and lipid fractions during 8 h after oral fat load
Hajer GR et al. Atherosclerosis 2009;202:216-24

5 Postprandial triglyceride content in lipoprotein fractions
Hajer GR et al. Atherosclerosis 2009;202:216-24

6 Postprandial cholesterol content in lipoprotein fractions
Hajer GR et al. Atherosclerosis 2009;202:216-24

7 Postprandial ApoB content in lipoprotein fractions
Hajer GR et al. Atherosclerosis 2009;202:216-24

Download ppt "Hajer GR et al. Atherosclerosis 2009;202:216-24"

Similar presentations

The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early sign of trouble: How can the inhibition of cholesterol absorption.

The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early sign of trouble: How can the inhibition of cholesterol absorption.
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51.

Weng TC, et al. J Clin Pharm Ther 2010;35:
RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes.

RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes.
Slide Source: www.lipidsonline.org Lipid and Lipoprotein Parameters at Baseline and Drug Treatment: METEOR Trial Baseline, Mean (SD) Time-Weighted Average.

Slide Source: Lipid and Lipoprotein Parameters at Baseline and Drug Treatment: METEOR Trial Baseline, Mean (SD) Time-Weighted Average.
Effect of 21-day Holistic Therapy at “Our Native Village Eco Resorts” on Diabetes Mellitus as assessed by blood glucose levels and consumption of oral.

Effect of 21-day Holistic Therapy at “Our Native Village Eco Resorts” on Diabetes Mellitus as assessed by blood glucose levels and consumption of oral.
Lipoproteins/Particles

Lipoproteins/Particles
Philip J. Barter, et al. Circulation 2011;124:555-562.

Philip J. Barter, et al. Circulation 2011;124:
Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:299-308.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:1556-1563.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:
Yunoki K et al. Atherosclerosis 2011 Epub Apr 22.

Yunoki K et al. Atherosclerosis 2011 Epub Apr 22.
Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:1561-73.

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:
Trial profile Prakash Deedwania, et al. Lancet 2006; 368: 919-28.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans Bonnie Ky, MD,* Anne Burke, MD,* Sotirios Tsimikas,

The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans Bonnie Ky, MD,* Anne Burke, MD,* Sotirios Tsimikas,
Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8

Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8
Dufaux, International Journal of Sports Medicine, 1982 TRIGLYCERIDES & TRAINING Increase Decrease No Change Numbers of Studies.

Dufaux, International Journal of Sports Medicine, 1982 TRIGLYCERIDES & TRAINING Increase Decrease No Change Numbers of Studies.
M.Sc. in Pharmacy/Clinical Laboratory Sciences

M.Sc. in Pharmacy/Clinical Laboratory Sciences
Westerweel PE et al. Eur Heart J 2008;29:

Westerweel PE et al. Eur Heart J 2008;29:
Independent variables (baseline) Loge (HOMA-IR) b P

Independent variables (baseline) Loge (HOMA-IR) b P
Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.

Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

Similar presentations

Ads by Google